Investment approach

Science-driven
healthcare expertise

Hands-on value
creation

Investment in
disruptive research

Founders

Friedrich Ackermann

Co-Founder

Friedrich previously worked as a management consultant (McKinsey & Company), investment banker (Morgan Stanley), private equity analyst (Partners Group) and entrepreneur in the health care industry. He holds a Master of Management from the London School of Economics.

Daniel
von Janowski

Co-Founder

Daniel previously worked as M&A investment banker (Evercore), management consultant (Roland Berger) and CEO in the diagnostics industry. Daniel holds a Masters of Management from the London School of Economics and also studied at TU Darmstadt and the Hong Kong University of Science and Technology.

Case Study

The A18i Capital team joined NeraCare GmbH in 2017 as investors and operating managers and has been leading the company’s strategy and operations since.

Through the leadership of A18i, NeraCare
has raised US$10m+ in funding and its main product MelaGenix was used in a landmark
clinical trail "NivoMela".

2017

A18i Capital invested
into NeraCare GmbH
in 2017

$10M

NeraCare has
raised $10m US

A18i Capital Ltd,

17/F Glenealy Tower,

No. 1 Glenealy, Central, Hong Kong